Cytokinetics Inc. buy Barclays PLC
Start price
24.04.25
/
50%
€33.60
Target price
24.04.26
€48.44
Performance (%)
63.39%
End price
25.04.26
€54.90
Summary
This prediction ended on 25.04.26 with a price of €54.90. The BUY prediction by Barclays_PLC for Cytokinetics Inc. saw massive gains of 63.39%. Barclays_PLC has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% | 104.294% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by Barclays_PLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $55.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.60
03.09.25
03.09.25
€61.04
03.09.26
03.09.26
60.10%
19.08.26
19.08.26
Stopped prediction by Barclays_PLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.52
06.04.26
06.04.26
€82.47
06.04.27
06.04.27
18.26%
19.08.26
19.08.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€53.50
28.01.26
28.01.26
€72.55
28.01.27
28.01.27
24.49%
19.08.26
19.08.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
08.05.25
08.05.25
€46.79
08.05.26
08.05.26
127.86%
09.05.26
09.05.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€46.40
23.05.24
23.05.24
€87.72
23.05.25
23.05.25
-42.24%
24.05.25
24.05.25